Monthly Archives: March 2013

Clinical Trials of Dabigatran in VTE. In 2008, DE was approved in Europe as being a key prevention of venous thromboembolic events in grownup individuals that have undergone elective complete hip replacement or complete knee replacement surgical treatment. In October … Continue reading →

These qualities, also on the bleeding risk along with other adverse results, may contribute to your frequent underuse of warfarin, specifically in elderly individuals . On top of that, VKAs possess a slow onset of action. This can be a … Continue reading →